Medical Oddities: Dogs share our mortality markers - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Medical Oddities: Dogs share our mortality markers

The bond with dogs runs deeper, the brain enjoys a good sweat, love on screen gets real, and tea carries a little more weight.

  • By

  • Teraya Smith

  • September 2, 2026

  • 5 min

Share

Objective:

To examine the association between plasma metabolites in dogs and all-cause mortality.

Approach:
  • Study Design: A longitudinal analysis from the Dog Aging Project involving 937 companion dogs.
  • Metabolite Analysis: 133 plasma metabolites were analyzed, adjusting for age, sex, weight, creatinine, and genetic relatedness.
  • Follow-Up: Average follow-up duration was 2.6 years, with 104 dogs dying during this period.
  • Comparison with Human Studies: Mortality associations for overlapping metabolites were compared with 5 independent human studies.
Key Findings:
  • 17% of metabolites were associated with all-cause mortality in dogs.
  • 23 metabolites met the statistical significance threshold.
  • 64% agreement in mortality associations for overlapping metabolites between dogs and humans.
  • Higher levels of pseudouridine, N2, N2-dimethylguanosine, and homocitrulline, and lower levels of deoxycarnitine and homoarginine were linked to mortality in both species.
Interpretation:

The findings indicate that dogs share biochemical markers of mortality with humans.

Limitations:
  • The study is limited to companion dogs and may not generalize to other species.
  • The follow-up period is shorter compared to human studies.
Conclusion:

Dogs may provide insights into mortality markers relevant to both species.

Sources:

Original Source(s)

Medical Oddities: Dogs share our mortality markers

  • by Teraya Smith

  • September 2, 2026

Related Content

Inside the hip osteoarthritis microbiome

Investigators compared intra-articular microbial profiles and predicted metabolic pathways in patients with hip osteoarthritis and nonarthritic controls.

Self-Sampling Shows Test Agreement

The study authors frame the device as a potential way to simplify screening, while emphasizing that larger validation studies are still needed.

High-Dose Vitamin C Could Pose Risk in Severe Burns

“High-dose intravenous vitamin C administered early after injury did not reduce organ dysfunction or [mortality] and should not be a treatment in severe burns.”